Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT01269853
Title Repeated Super-selective Intraarterial Cerebral Infusion of Bevacizumab (Avastin) for Treatment of Relapsed GBM and AA
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors North Shore Long Island Jewish Health System
Indications

mixed oligodendroglioma-astrocytoma

malignant astrocytoma

glioblastoma

Therapies

Bevacizumab

Age Groups: adult
Covered Countries USA


No variant requirements are available.